Ottai M8 - Page 45

45
¼ěãƑßřňąģùŔāã¼ØīűãŅãňąīß˚
ɢɦ˻AąùāùěřÙīŌãßãŔãÙŔąīģŌřÙÙãŌŌň¼Ŕã¼ģßø¼ąěřňãň¼Ŕã˺ą˚ã˚
ŌŅãÙąƍÙąŔŸ˻˚AąùāùěřÙīŌãßãŔãÙŔąīģŌřÙÙãŌŌň¼ŔãąŌŔāã
ŅňīŅīƑąīģīø)T;¼ěŌīßãŔãÙŔąģùāąùāùěřÙīŌãŲąŔāąģ
30 minutes before and after the continuous glucose
ġīģąŔīňąģùŌŸŌŔãġŅňīġŅŔŌ¼āąùāùěřÙīŌããűãģŔ˚āã
āąùāùěřÙīŌãßãŔãÙŔąīģø¼ąěřňãň¼ŔãąŌŔāãŅňīŅīƑąīģ
of EKF that does not detect high glucose within 30
minutes before and after the continuous glucose
monitoring system prompts a high glucose event.
āãÙěąģąÙ¼ěŅãƐīňġ¼ģÙãŔãŌŔňãŌřěŔŌīøŔāąŌŅňīßřÙŔŌāąùā
¼ģßěīŲùěřÙīŌã¼ěãƑŌ¼ňãŌřġġ¼ňąƀãß¼ŌøīěěīŲŌ˜
AŸŅīùěŸÙãġą¼¼ěãƑ
success rate and
loss Failure rate (i.e.
sensitivity)
Success
rate
84.1% 88.0% 12.0% 95.8% 4.2% 95.7% 4.3%15.9%
Success
rate
Success
rate
Success
rate
Failure
rate
Failure
rate
Failure
rate
Failure
rate
Success and loss
īøāŸŅīùěŸÙãġą¼
detection Failure rate
˺ą˚ã˚ŌŅãÙąƍÙąŔŸ˻
Success and loss
īøāŸŅãňùěŸÙãġą¼
detection Failure rate
˺ą˚ã˚ŌŅãÙąƍÙąŔŸ˻
Success and loss
īøāŸŅãňùěŸÙãġą¼
detection Failure rate
˺ą˚ã˚ŌŅãÙąƍÙąŔŸ˻
Note:
ɢɣ˻āãāąùā˫ěīŲùěřÙīŌã¼ěãƑøřģÙŔąīģąŌīģěŸřŌãßŔī
ŅňīġŅŔŔāãřŌãňŔīġã¼ŌřňãùěřÙīŌãŲąŔāƍģùãƑąŅ
ØěīīßřŌąģù¼<\˛¼ģßąŌģīŔřŌãß¼Ō¼ؼŌąŌøīň
deciding and adjusting treatment plans.
ɢɤ˻āãŅãƐīňġ¼ģÙãīøŔāãŅňīßřÙŔŌāąùā˫ěīŲùěřÙīŌã
¼ěãƑøřģÙŔąīģŌā¼ŌØããģãű¼ěř¼ŔãßŔāňīřùāÙěąģąÙ¼ě
Ŕňą¼ěŌ˚āã¼ěãƑŔāňãŌāīěßŌøīňāąùā˫ěīŲùěřÙīŌã¼ňã
ąģąŔą¼ěěŸŌãŔŔī˜<ěřÙīŌãɣɣ˚ɣġġīě˫Vīňɤɢɢġù˫
ßVŲąěěŅňīġŅŔ¼āąùāùěřÙīŌã¼ěãƑ˛¼ģßùěřÙīŌã
<4.4mmol/L or 79mg/dL will prompt a low glucose
¼ěãƑ˚āãāąùā˫ěīŲùěřÙīŌã¼ěãƑŔāňãŌāīěßŌąģ
clinical trials are only recommended values for
subjects in clinical trials. Users can customize the